RATIONAL DESIGN OF BREAST TUMOR IMAGING AGENTS
乳腺肿瘤显像剂的合理设计
基本信息
- 批准号:3167035
- 负责人:
- 金额:$ 14.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-01-01 至 1988-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Estrogen receptors that are present in the majority of human breast tumors
provide a selective uptake mechanism for estrogens. Thus, in principle, it
should be possible to image human breast tumors with gamma-emitting
estrogens haveing suitable binding selectivity and sufficiently high
specific activity, and thus to locate primary and metastatic tumors that
are estrogen receptor-positive and to assay their receptor content in situ.
We have developed a measure of binding selectivity (the binding selectivity
index) that can be used to assist in the development of optimal imaging
agents. Using this index as a guide, we have prepared 16delta-bromo
estrogens, labeled with Br-77 at high specific activity, and we have
demonstrated that they are taken up with high selectivity by estrogen
target tissues. They could also be used to image mammary tumors in animals
and in human breast cancer patients, in preliminary studies. However, the
effective use of tumor imaging agents in humans will require shorter
half-life isotopes, capable of providing much higher resolution images.
Thus, we are developing syntheses of several positron-emitting (F-18, C-11)
estrogens that will be used in conjunction with positron tomographic
detectors to provide three-dimensional images of human breast tumors. We
will also study halofluorination and fluoride additions to iron pentadienyl
cation complexes as part of a more general development of fluorination
methods suitable for F-18 labeling without carrier dilution. The target
tissue and mammary tumor uptake selectivity of the gamma-emitting estrogens
will be studied in experimental animals. We will also try to validate a
pharmacokinetic model that will enable receptor site concentration and
affinity to be determined by analysis of target tissue and blood activity
profiles.
The successful development of such imaging agents should assist in the
detection of breast tumors and improve the prediction of response to
hormone therapy.
大多数人类乳腺肿瘤中存在的雌激素受体
为雌激素提供选择性摄取机制。因此,原则上,它
应该可以用伽马射线对人类乳腺肿瘤进行成像
具有合适的结合选择性和足够高的雌激素
特定的活性,从而定位原发和转移的肿瘤
雌激素受体呈阳性,并原位测定其受体含量。
我们已经开发出一种结合选择性的测量方法(结合选择性
索引),可用于协助开发最佳成像
探员们。以这一指标为指导,我们制备了16个三角洲溴化物
雌激素,用BR-77标记,具有高比活性,我们有
表明雌激素对它们有很高的选择性
目标组织。它们还可以用来对动物的乳腺肿瘤进行成像。
在初步研究中,在人类乳腺癌患者中。然而,
在人类中有效使用肿瘤显像剂需要更短的时间
半衰期同位素,能够提供更高分辨率的图像。
因此,我们正在开发几种正电子发射(F-18,C-11)的合成。
雌激素将与正电子断层扫描结合使用
探测器提供人类乳房肿瘤的三维图像。我们
我还将研究卤化氟化和向五二烯基铁中添加氟化物
阳离子络合物作为氟化更一般发展的一部分
适用于无载体稀释的F-18标记方法。目标是
放射类雌激素对组织和乳腺肿瘤摄取的选择性
将在实验动物身上进行研究。我们还将尝试验证一个
药代动力学模型将使受体部位浓度和
通过分析靶组织和血液活性来确定亲和力
配置文件。
这种显像剂的成功开发应该有助于
检测乳腺肿瘤并提高对
激素疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN A. KATZENELLENBOGEN其他文献
JOHN A. KATZENELLENBOGEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN A. KATZENELLENBOGEN', 18)}}的其他基金
PHYTOESTROGEN ACTION THROUGH ESTROGEN RECEPTORS a & B
植物雌激素通过雌激素受体发挥作用
- 批准号:
6856243 - 财政年份:2004
- 资助金额:
$ 14.62万 - 项目类别:
LIGAND INDUCED CONFORMATION CHANGES IN STEROID NEAPHNS
配体诱导类固醇原子构象变化
- 批准号:
6252687 - 财政年份:1997
- 资助金额:
$ 14.62万 - 项目类别:
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor Activity
实现选择性核受体活性的新型配体和机制
- 批准号:
8897327 - 财政年份:1992
- 资助金额:
$ 14.62万 - 项目类别:
相似海外基金
Organizational effects of early-life exposure to low-dose bisphenol-A and diethylstilbestrol on hypothalamic circuits regulating energy balance
生命早期接触低剂量双酚 A 和己烯雌酚对调节能量平衡的下丘脑回路的组织影响
- 批准号:
263246 - 财政年份:2012
- 资助金额:
$ 14.62万 - 项目类别:
Prenatal Developmental Immunotoxicity of Diethylstilbestrol and Methoxychlor
己烯雌酚和甲氧滴滴涕的产前发育免疫毒性
- 批准号:
8089807 - 财政年份:2010
- 资助金额:
$ 14.62万 - 项目类别:
Prenatal Developmental Immunotoxicity of Diethylstilbestrol and Methoxychlor
己烯雌酚和甲氧滴滴涕的产前发育免疫毒性
- 批准号:
8301056 - 财政年份:2009
- 资助金额:
$ 14.62万 - 项目类别:
Prenatal Developmental Immunotoxicity of Diethylstilbestrol and Methoxychlor
己烯雌酚和甲氧滴滴涕的产前发育免疫毒性
- 批准号:
8267799 - 财政年份:2009
- 资助金额:
$ 14.62万 - 项目类别:
Genital tract malformation and angiogenesis in the female mice exposed to diethylstilbestrol neonatally
新生雌性己烯雌酚暴露后生殖道畸形和血管生成
- 批准号:
18590195 - 财政年份:2006
- 资助金额:
$ 14.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of the effects of diethylstilbestrol, an endocrine disruptors, on synaptic plasticity and its application as an detailed test
阐明内分泌干扰物己烯雌酚对突触可塑性的影响及其作为详细测试的应用
- 批准号:
15590110 - 财政年份:2003
- 资助金额:
$ 14.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of fetal and neonatal exposure of male mice to diethylstilbestrol as endocrine disrupter on the reproductive and neuroendocrine system
雄性小鼠胎儿和新生儿暴露于己烯雌酚作为内分泌干扰物对生殖和神经内分泌系统的影响
- 批准号:
12836014 - 财政年份:2000
- 资助金额:
$ 14.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)